Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Found

By GLP-1 ScorecardUpdated

Our take

I would look at Found first if I wanted to compare an insurance-based visit with cash-pay care. If I only wanted a self-pay prescription quote, I would ask both providers for the first and next bills before deciding.

CoreAge Rx: ask for the charge before clinical review

The CoreAge Rx review documents different starting prices and refund wording across its pages. Ask what the first charge buys and what you would get back if a clinician declines to prescribe.

Read the CoreAge Rx review →

Found: price the 28-day refill and any labs

The Found review separates introductory and later charges on the 28-day compounded cash plan. Ask what labs would cost and, if using insurance for visits, what you would pay for the visits and prescription separately.

Read the Found review →
Payment and renewal details

Found

Cash compounded plan
$149 initially, then $269/28 days semaglutide; $199 initially, then $339/28 days tirzepatide; each 28-day cycle
Included and extra
Compounded medication, care and membership included; labs extra. Branded medication and insurance clinical cost-sharing are separate
Longer-plan advertisements
$149 / $199 per advertised cycle on twelve-term plans; exact debit and calendar coverage unresolved
Cancellation and refund
48-hour renewal-cancellation recommendation; terms describe 24-hour processing. Consultation/three-day refund clauses conflict; renewal fees generally nonrefundable

Compare the same supply and billing period. Insurance-based visits do not establish coverage for the prescription.

CoreAge Rx
Site position #1

Higher score

FoundFactor scores not reassessed.
Site position #7

Lower score

Score comparison

CoreAge Rx has the higher recorded score — 89.5/100 to 83.5/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

CoreAge Rx scores 89.5/100 (B+).

Before you choose

Before comparing the headline prices, the CoreAge Rx review and the Found review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CoreAge Rx vs Framework and Corsica Health vs Found compare each of them with another graded program, and the list of alternatives to CoreAge Rx ranks the programs closest to CoreAge Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoreAge Rx +14
92
78
Dose & formulationFound +6
88
94
Clinical oversightCoreAge Rx +7
93
86
Labs & monitoringCoreAge Rx +8
90
82
FulfillmentCoreAge Rx +11
95
84
Contract termsFound +3
67
70
CoreAge Rx · top barFound · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxFound
WeighScore89.5/10083.5/100
GradeB+B
Site position#1#7
SemaglutideProduct page from $79/mo; navigation $99. Confirm selected quote.$149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)
TirzepatideFrom $129/mo advertised; confirm selected charge, supply and renewal.$199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)
CoverageUS only; therapy-specific state restrictions applyU.S. service with state, treatment and insurance restrictions; confirm your eligibility
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedYes
CoreAge Rx

Site position #1 · B+

Strengths

  • Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
  • Advertises the same price across doses and no membership fee
  • Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy

What to consider

  • Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
  • FAQ no-rebill and payment-timing statements differ from the subscription and order policy
  • FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
  • Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
  • Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Found

Site position #7 · B

Factor scores not reassessed.

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard